Oral delivery of hydrophilic drugs to the brain

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/18 (2006.01) A61K 47/36 (2006.01) A61K 47/48 (2006.01)

Patent

CA 2754140

A composition comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy wherein the composition is orally administered to the human or animal body. The invention includes derivatives such as palmitoylated Leucine [5]-Enkephalin and is useful in the treatment of schizophrenia, obsesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.

La présente invention concerne une composition comprenant un dérivé lipophile d'un médicament hydrophile et un composé amphiphile destiné à être utilisé en thérapie, la composition étant administrée par voie orale au corps humain ou animal. L'invention concerne des dérivés tels que la leucine[5]-encéphaline palmitoylée et est utile dans le traitement de la schizophrénie, de l'obésité, de la douleur et des troubles du sommeil, de maladies psychiatriques, de troubles neurodégénératifs, de cancers du cerveau et de maladies infectieuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oral delivery of hydrophilic drugs to the brain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral delivery of hydrophilic drugs to the brain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral delivery of hydrophilic drugs to the brain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1929649

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.